Lisa Bodei - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lisa Bodei

Showing results (101-110 of 184) with videos related to

Pageof 19

Sort By:

Cancer Biotherapy & Radiopharmaceuticals|July 10, 2014

Planning combined treatments of external beam radiation therapy and molecular radiotherapyMarta Cremonesi, Mahila Ferrari, Francesca Botta, et al.

Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009

Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOCMaribel L Sierra, Alberto Agazzi, Lisa Bodei, et al.

Endocrine Connections|March 14, 2019

NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imagingAnna Malczewska, Magdalena Witkowska, Karolina Makulik, et al.

European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2015

Feasibility and utility of re-treatment with (177)Lu-DOTATATE in GEP-NENs relapsed after treatment with (90)Y-DOTATOCStefano Severi, Maddalena Sansovini, Annarita Ianniello, et al.

Pituitary|April 27, 2007

Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature reviewUmberto Goglia, Diego Ferone, Marilena Sidoti, et al.

The Prostate|April 4, 2024

Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole bloodIrvin M Modlin, Mark Kidd, Ignat A Drozdov, et al.

European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2009

Peptide receptor radionuclide therapy with (90)Y-DOTATOC in recurrent meningiomaMirco Bartolomei, Lisa Bodei, Concetta De Cicco, et al.

Journal of Neuro-Oncology|June 1, 2005

Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastomaAmerigo Boiardi, Mirco Bartolomei, Antonio Silvani, et al.

European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2018

Biodistribution and radiation dose estimates for <sup>68</sup>Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumorsSimone Krebs, Neeta Pandit-Taskar, Diane Reidy, et al.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|November 19, 2015

Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerationsAnna Sarnelli, Francesco Guerriero, Francesca Botta, et al.

Pageof 19

Search research articles

Showing results (101-110 of 184) with videos related to